Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026)
Aytu Biopharma (AYTU) posted quarterly Amortization of Deferred Charges of $27000.0 for Q1 2026, little changed year-over-year from $27000.0 in Q1 2025, and down 6.9% quarter-over-quarter from $29000.0 in Q4 2025.
Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Amortization of Deferred Charges for 8 consecutive years, with $27000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $27000.0; the TTM figure through Mar 2026 stood at $111000.0 (down 48.61% YoY), while the FY2025 annual figure was $108000.0, down 81.91% from the prior year.
- Amortization of Deferred Charges fell to $27000.0 in Q1 2026 per AYTU's latest filing, from $29000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $170000.0 in Q4 2022 and bottomed at $26000.0 in Q2 2025.
- Historically, Amortization of Deferred Charges has averaged $93588.2 across 5 years, with a median of $100000.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 203.03% — and 2025, when it plunged 83.23%.
- Aytu Biopharma's Amortization of Deferred Charges stood at $170000.0 in 2022, then dropped by 9.41% to $154000.0 in 2023, then slumped by 81.82% to $28000.0 in 2024, then grew by 3.57% to $29000.0 in 2025, then declined by 6.9% to $27000.0 in 2026.
- Business Quant data shows AYTU's Amortization of Deferred Charges at $27000.0 in Q1 2026, $29000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Dec 31, 2023 | 154,000.00 |